Advertisement

Clinical Drug Investigation

, Volume 39, Issue 9, pp 899–908 | Cite as

Hypertension and Health-Related Quality of Life (HRQoL): Evidence from the US Hispanic Population

  • Elizabeth Riley
  • Jongwha ChangEmail author
  • Chanhyun Park
  • Sean Kim
  • Inho Song
Original Research Article

Abstract

Background and Objective

Little evidence exists regarding the marginal decrease in health-related quality of life (HRQoL) in relation to the presence of hypertension among a Hispanic population based on US population-based research.

Method

This cross-sectional study used data from the 2014 to 2015 Medical Expenditure Panel Survey (MEPS). The target population was comprised of Hispanic community-dwelling residents with hypertension in the USA. The independent variable was the presence of hypertension. The dependent variable was HRQoL, which was measured using the Short Form-12 (SF-12) physical health composite scale (PCS) and mental health composite scale (MCS).

Results

A total of 13,933 members of the Hispanic population met the study inclusion criteria, and the estimated population size was 36,440,400 Hispanics. Among them, 82.9% did not have any hypertensive condition (n = 11,466), while 17.7% had some hypertensive condition (n = 2467). SF-12 PCS scores (95% CI) were 46.62 (45.68–47.57) in the Hispanic population with hypertension and 51.62 (51.1–52.14) in the Hispanic population without hypertension. SF-12 MCS scores (95% CI) were 52.67 (52.07–53.27) in patients without hypertension and 50.35 (49.45–51.26) in the Hispanic population with hypertensive conditions.

Conclusion

The presence of hypertension was associated with lower HRQoL in the Hispanic population. Based on our findings, we suggest that healthcare providers should monitor a hypertensive minority population for anxiety and mood disorders and recommend psychiatric assessment and treatment if appropriate.

Notes

Compliance with Ethical Standards

Conflict of interest

Elizabeth Riley, Chanhyun Park, Sean Kim, Inho Song, and Jongwha Chang declare no conflicts of interest.

Funding

This project was supported by a UTEP School of Pharmacy Seed Grant (226811487A).

Ethics approval

Institutional Review Board (IRB) approval was waived since MEPS is a publicly available de-identified dataset.

References

  1. 1.
    Hayes DK, Denny CH, Keenan NL, Croft JB, Greenlund KJ. Health-related quality of life and hypertension status, awareness, treatment, and control: National health and nutrition examination survey, 2001–2004. J Hypertens. 2008;26(4):641–7.  https://doi.org/10.1097/HJH.0b013e3282f3eb50.CrossRefPubMedGoogle Scholar
  2. 2.
    Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–357.CrossRefPubMedGoogle Scholar
  3. 3.
    Gusmão JL, Mion D, Pierin AM. Health-related quality of life and blood pressure control in hypertensive patients with and without complications. Clinics (Sao Paulo). 2009;64(7):619–28.CrossRefPubMedCentralGoogle Scholar
  4. 4.
    Whelton PK, Carey RM, Aronow WS, Casey D, Collins KJ, Himmelfarb CD, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PNCA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13–115.PubMedGoogle Scholar
  5. 5.
    Hypertension Among Adults in the United States: National Health and Nutrition Examination Survey, 2011–2012. Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/data/databriefs/db133.htm#x2013;2012. Published October 31, 2013. Accessed 29 Jan 2019.
  6. 6.
    Sánchez V, Cacari Stone L, Moffett ML, Nguyen P, Muhammad M, Bruna-Lewis S, Urias-Chauvin R. Process evaluation of a promotora de salud intervention for improving hypertension outcomes for latinos living in a rural US-mexico border region. Health Promot Pract. 2014;15(3):356–64.CrossRefPubMedGoogle Scholar
  7. 7.
    López-Candales A. Importance of the hispanic heritage regarding diagnosis and management of hypertension. Postgrad Med. 2015;127(6):571–2.CrossRefPubMedGoogle Scholar
  8. 8.
    Saleem F, Hassali MA, Shafie AA. A cross-sectional assessment of health-related quality of life (HRQoL) among hypertensive patients in pakistan. Health Expect. 2014;17(3):388–95.CrossRefPubMedGoogle Scholar
  9. 9.
    Zhang Y, Zhou Z, Gao J, Wang D, Zhang Q, Zhou Z, Su M, Li D. Health-related quality of life and its influencing factors for patients with hypertension: evidence from the urban and rural areas of shaanxi province, china. BMC Health Serv Res. 2016;16:277.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Trevisol DJ, Moreira LB, Fuchs FD, Fuchs SC. Health-related quality of life is worse in individuals with hypertension under drug treatment: results of population-based study. J Hum Hypertens. 2012;26(6):374–80.CrossRefPubMedGoogle Scholar
  11. 11.
    Theodorou M, Kaitelidou D, Galanis P, Middleton N, Theodorou P, Stafylas P, et al. Quality of life measurement in patients with hypertension in Cyprus. Hellenic J Cardiol. 2011;52:407–15.PubMedGoogle Scholar
  12. 12.
    Marianne A, Dan B-O. Hypertension and quality of life: the disease, the treatment or a combination of both. Psychol Health. 1996;11(5):685–95.CrossRefGoogle Scholar
  13. 13.
    Katsi V, Kallistratos MS, Kontoangelos K, et al. Arterial hypertension and health-related quality of life. Front Psychiatry. 2017;8:270.  https://doi.org/10.3389/fpsyt.2017.00270 (Published 2017 Dec 4).CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Fox C, Golden S, Anderson C, Bray G, Burke L, de Boer I, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2015;38(9):1777–803.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Schmieder R, Ruilope L. Blood pressure control in patients with comorbidities. J Clin Hypertens (Greenwich Conn.). 2008;10:624–31.CrossRefGoogle Scholar
  16. 16.
    Mengden T, Ligges U, Mielke J, Bramlage P, Korzinek A, Sehnert W. Blood pressure control and cardiovascular risk in hypertensive patients with type 2 diabetes: the german T2Target registry. J Clin Hypertens. 2017;19(8):757–63.  https://doi.org/10.1111/jch.13001.CrossRefGoogle Scholar
  17. 17.
    McLean DL, Simpson SH, McAlister FA, et al. Treatment and blood pressure control in 47,964 people with diabetes and hypertension: a systematic review of observational studies. Can J Cardiol. 2006;22:855–60.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Weycker D, Nichols GA, O’Keefe-Rosetti M, et al. Risk-factor clustering and cardiovascular disease risk in hypertensive patients. Am J Hypertens. 2007;20:599–607.CrossRefPubMedGoogle Scholar
  19. 19.
    Chen G, McAlister FA, Walker RL, et al. Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure. Hypertension. 2011;57:891–7.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Vega WA, Rodriguez MA, Gruskin E. Health disparities in the Latino population. Epidemiol Rev. 2009;31:99–112.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Meps.ahrq.gov [Medical Expenditure Panel Survey Background]. Agency for Healthcare Research and Quality. Available at http://meps.ahrq.gov/mepsweb/about_meps/survey_back.jsp. Accessed 31 Jan 2019.
  22. 22.
    Cohen SB. Design strategies and innovations in the medical expenditure panel survey. Med Care. 2003;41(Suppl 7):III5–12.PubMedGoogle Scholar
  23. 23.
    Cheak-Zamora N, Wyrwich K, McBride T. Reliability and validity of the SF-12v2 in the medical expenditure panel survey. Qual Life Res. 2009;18(6):727–35.CrossRefPubMedGoogle Scholar
  24. 24.
    Jayasinghe UW, Harris MF, Taggart J, Christl B, Black DA. Gender differences in health-related quality of life of Australian chronically-ill adults: patient and physician characteristics do matter. Health Qual Life Outcomes. 2013;11:102.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Trevisol DJ, Moreira LB, Kerkhoff A, Fuchs SC, Fuchs FD. Health-related quality of life and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens. 2011;29:179–88.CrossRefPubMedGoogle Scholar
  26. 26.
    Park C, Fang J, Hawkins NA, Wang G. Comorbidity status and annual total medical expenditures in US hypentensive aduts. Am J Prev Med. 2017;53(6S2):S172–81.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    González-Chica DA, Hill CL, Gill TK, Hay P, Haag D, Stocks N. Individual diseases or clustering of health conditions? Association between multiple chronic diseases and health-related quality of life in adults. Health Qual Life Outcomes. 2017;15(1):244.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes. 2004;2:51.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Hajian-Tilaki K, Heidari B, Hajian-Tilaki A. Are gender differences in health-related quality of life attributable to sociodemographic characteristics and chronic disease conditions in elderly people? Int J Prev Med. 2017;8:95.PubMedPubMedCentralGoogle Scholar
  30. 30.
    Robinson MR, Daniel LC, O’Hara EA, Szabo MM, Barakat LP. Insurance status as a sociodemographic risk factor for functional outcomes and health-related quality of life among youth with sickle cell disease. J Pediatr Hematol Oncol. 2014;36(1):51–6.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Porter A, Fischer MJ, Brooks D, Bruce M, Charleston J, Cleveland WH, et al. Quality of live and psychosocial factors in African American with Hypertensive Chronic Kidney Disease. Transl Res. 2012;159(1):4–11.CrossRefPubMedGoogle Scholar
  32. 32.
    Burdine JN, Felix MR, Abel AL, Wiltraut CJ, Musselman YJ. The SF-12 as a population health measure: an exploratory examination of potential for application. Health Serv Res. 2000;35(4):885–904.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Elizabeth Riley
    • 1
  • Jongwha Chang
    • 1
    Email author
  • Chanhyun Park
    • 2
  • Sean Kim
    • 3
  • Inho Song
    • 4
  1. 1.Department of Pharmacy Practice, School of PharmacyUniversity of Texas at El PasoEl PasoUSA
  2. 2.School of PharmacyNortheastern UniversityBostonUSA
  3. 3.School of PharmacyShenandoah UniversityWinchesterUSA
  4. 4.Korea Development InstituteSejongSouth Korea

Personalised recommendations